Effects Of Disease On The Healthcare Industry Respira 610621

effects Of Disease On The Health Care Industry Respiratory

Complete the table below for 2 diseases that you have chosen that affects respiratory health. In each box, you are required to list 3-5 bulleted statements regarding the heading of that box. Cite your sources using APA format. Chosen Respiratory Disease or Disorder Treatment Modalities Cultural Beliefs/Practices Affecting this Disease Epidemiological Statistics Available Consumer Resources (ex. financing, information, support) Impact on Society List chosen disease here · · · · · · List chosen disease here · · · · · · References:

Paper For Above instruction

Respiratory diseases significantly impact the healthcare industry, influencing treatment modalities, cultural practices, epidemiological trends, resource allocation, and societal perceptions. This paper explores two prevalent respiratory conditions—Chronic Obstructive Pulmonary Disease (COPD) and asthma—analyzing how they influence healthcare delivery, the role of cultural beliefs, epidemiological data, available resources, societal impacts, and preventive considerations.

Chosen Diseases

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma

Treatment Modalities

  • For COPD: Pharmacotherapy with bronchodilators and corticosteroids, pulmonary rehabilitation, oxygen therapy, and surgical interventions such as lung volume reduction surgery (Global Initiative for Chronic Obstructive Lung Disease, 2023).
  • For Asthma: Inhaled corticosteroids, beta-agonists (short and long-acting), leukotriene modifiers, and immunotherapy (National Heart, Lung, and Blood Institute, 2020).

Cultural Beliefs/Practices Affecting these Diseases

  • Cultural acceptance of smoking, including hookah use, exacerbates COPD and asthma prevalence, especially in Middle Eastern societies where hookah smoking is culturally ingrained (Smith et al., 2019).
  • Beliefs in traditional medicine can delay conventional treatment, affecting disease management outcomes (Lee & Lee, 2018).

Epidemiological Statistics

  • According to the WHO, COPD is the third leading cause of death worldwide, with an estimated 251 million cases globally (WHO, 2023).
  • Asthma affects approximately 262 million people globally, with higher prevalence reported in children and urban populations (Global Asthma Network, 2018).

Available Consumer Resources

  • Insurance coverage and government-funded programs such as Medicaid and Medicare in the United States facilitate access to treatment (American Lung Association, 2021).
  • Patient education programs and support groups improve disease management and quality of life (National Heart, Lung, and Blood Institute, 2020).

Impact on Society

  • Chronic respiratory diseases contribute to reduced workforce productivity and increased healthcare costs (World Bank, 2020).
  • They impose a significant emotional and financial burden on families and caregivers (American Thoracic Society, 2022).

Influence of Culture and Beliefs on Disease and Treatment

2a. My Opinion

Cultural norms, especially around smoking, heavily influence respiratory disease prevalence. Practices like hookah smoking are socially accepted in some cultures, which can hinder prevention efforts. Additionally, beliefs in traditional remedies may delay seeking medical care, prolonging disease progression.

2b. Other Source

Research indicates that cultural acceptance of smoking and reliance on traditional medicine are significant barriers to effective management of respiratory diseases (Smith et al., 2019; Lee & Lee, 2018).

Respiratory Diseases Concerned for the Elderly and Infants

3a. My Opinion

The elderly are particularly vulnerable to COPD exacerbations due to age-related decline in lung function, while infants are at risk of respiratory distress syndrome and bronchiolitis caused by immature immune systems and smaller airways.

3b. Other Source

Studies show that COPD exacerbations are a leading cause of hospitalization among the elderly, and bronchiolitis in infants can lead to hospitalization and even long-term respiratory issues (Centers for Disease Control and Prevention [CDC], 2020).

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease is a progressive respiratory disorder characterized by airflow limitation that is not fully reversible. It encompasses emphysema and chronic bronchitis, primarily caused by long-term exposure to tobacco smoke, environmental pollutants, and occupational hazards (GOLD, 2023). The disease's progression leads to declining lung function, reduced exercise capacity, and increased risk of respiratory infections.

Societal Impact and Treatment Modalities

Societally, COPD incurs high economic costs due to hospitalizations, medication, and long-term care needs. It also diminishes productivity and increases caregiver burden. Treatment primarily focuses on symptomatic relief, smoking cessation, pulmonary rehabilitation, and oxygen therapy. Emerging therapies include gene therapy and novel pharmacologic agents aimed at slowing disease progression (Barnes et al., 2019).

Personal Reflection

From my perspective, COPD represents a significant public health challenge due to its preventability and the extensive resources needed for management. Early detection and emphasizing smoking cessation can greatly influence disease trajectory.

Asthma in Children

Asthma is a chronic airway inflammatory disease that significantly impacts children’s health and daily activities. It causes episodic wheezing, breathlessness, and coughing, often triggered by allergens, pollutants, or exercise (NHLBI, 2020). In childhood, uncontrolled asthma can impair growth, development, and school attendance, leading to emotional and social challenges.

Societal View and Ethical Concerns

Society has shifted from viewing smoking as socially acceptable to recognizing its health hazards, especially post the tobacco lawsuits and public health campaigns. Ethical concerns related to smoking include the harm caused to others via secondhand smoke, environmental pollution, and the targeted marketing of tobacco products to vulnerable populations (World Health Organization [WHO], 2020).

Changing Perspectives

Over the years, policies banning smoking in public places and awareness campaigns have decreased smoking rates. However, challenges persist with e-cigarettes and tobacco advertising targeting youth, raising ethical questions about corporate responsibility.

Conclusion

Respiratory diseases like COPD and asthma impose substantial burdens on individuals and society, influenced heavily by cultural practices and socioeconomic factors. Effective management relies on early detection, public health initiatives, and culturally sensitive educational campaigns. Societal perceptions of smoking have evolved considerably, highlighting the importance of ethical considerations in public health policymaking. Continued efforts are essential to reduce disease prevalence, improve treatments, and foster healthier communities worldwide.

References

  • American Lung Association. (2021). Lung disease statistics. https://www.lung.org/lung-health-diseases
  • Barnes, P. J., Celli, B., Lutter, R., & Brusselle, G. (2019). Advances in COPD management. The European Respiratory Journal, 54(2), 190-205.
  • Centers for Disease Control and Prevention. (2020). Respiratory diseases in infants and the elderly. https://www.cdc.gov/respiratory-diseases
  • Global Initiative for Chronic Obstructive Lung Disease. (2023). GOLD guidelines for COPD. https://goldcopd.org
  • Global Asthma Network. (2018). The global asthma report 2018. https://ginasthma.org
  • Lee, S. J., & Lee, S. H. (2018). Cultural influences on health behaviors. Journal of Cultural Medicine, 12(4), 211-219.
  • National Heart, Lung, and Blood Institute. (2020). Asthma management guidelines. https://www.nhlbi.nih.gov
  • Smith, J., Patel, V., & Nguyen, T. (2019). Cultural practices and respiratory health. International Journal of Public Health, 64(7), 1075-1084.
  • World Bank. (2020). The economic impact of chronic respiratory diseases. https://www.worldbank.org
  • World Health Organization. (2023). Global surveillance data on COPD. https://www.who.int

Related Assignments